| Keywords: |
cancer recurrence; cancer adjuvant therapy; cancer staging; diagnostic accuracy; sensitivity and specificity; neoplasms; medical decision making; biological marker; prostate specific antigen; tumor markers, biological; odds ratio; editorial; tumor biopsy; uvomorulin; prediction; risk assessment; prostate cancer; prostatic neoplasms; prostatectomy; disease progression; models, statistical; scoring system; predictive value of tests; interleukin 6; transforming growth factor beta1; outcomes research; multivariate analysis; seminal vesicle; thymoma; statistical model; nomogram; hazard assessment; humans; prognosis; human; male; priority journal
|
